The Role of ARID1A in the Nonestrogenic Modulation of IGF-1 Signaling.

Sham JdeedEdina ErdősBálint László Bálint Iván P Uray

Published in: Molecular cancer research : MCR (2022)

This study underscores the possibility of the pharmacologic modulation of the ARID1A factor to downregulate protumorigenic IGF-1 activity in patients with postmenopausal breast cancer undergoing aromatase inhibitor treatment.

Keyphrases

binding protein
pi k akt
bone mineral density
signaling pathway
cell proliferation
smoking cessation